Rigorous science for the organizations building healthy aging.
I provide scientific and strategic guidance to organizations working in aging biology, biotechnology and preventive health, from research institutes setting a ten-year vision to companies translating aging science for the public.
Chief Scientific Advisor, The WNDR Lab.
Since 2025 I have been Chief Scientific Advisor to The WNDR Lab (WndrHLTH) in Boston: scientific lead for a consumer healthy-aging venture, responsible for evidence standards, product science and public communication.
Two episodes of The WNDR Lab’s LIVING Room podcast feature conversations with me; you can find them on the Media page.
Scientific advisory roles.
- 2026–Steering Committee, DiAL Health 2.0 ConsortiumMulti-site study led by Pennington Biomedical Research Center
- 2025–Scientific Advisory Board, Babraham InstituteCambridge, UK: aging research strategy and ten-year science vision
- 2025–International Advisory Board, Center for Aging Research (CARe)UNICAMP, Brazil
- 2021–External Advisory Board, Bakar Aging Research InstituteUniversity of California San Francisco
- 2020–National Scientific Advisory CouncilAmerican Federation for Aging Research (AFAR)
Research with industry.
- 2026–2028Danone Institute North AmericaResearch partnership with the Harvard Chan Healthy Aging Initiative: Healthy Aging Symposium and Pilot Grant Program
- 2018–2022AbbVieSponsored research on neuron-specific tau models of Alzheimer’s disease in C. elegans
Scientific strategy
Research direction and long-range science vision.
Evidence review
What the data on an intervention or claim do, and don’t, support.
Advisory boards
Scientific advisory boards for institutes and companies.
Communication
Explaining aging science accurately to the public.
All of my external relationships are disclosed and managed under the Harvard T.H. Chan School of Public Health conflict-of-interest policy.